✦ LIBER ✦

Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study

✍ Scribed by Keystone, E.; Genovese, M. C.; Klareskog, L.; Hsia, E. C.; Hall, S.; Miranda, P. C.; Pazdur, J.; Bae, S.-C.; Palmer, W.; Xu, S.; Rahman, M. U.

Book ID: 126220725
Publisher: BMJ Publishing Group
Year: 2010
Tongue: English
Weight: 229 KB
Volume: 69
Category: Article
ISSN: 0003-4967
DOI: 10.1136/ard.2009.116319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of golimumab on radiographic

The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy

✍ Paul Emery; Roy Fleischmann; Désirée van der Heijde; Edward C. Keystone; Mark C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

Golimumab in patients with active rheuma

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Erratum: The effects of golimumab on rad

Erratum: The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy

✍ Paul Emery; Roy Fleischmann; Désirée van der Heijde; Edward C. Keystone; Mark C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

Erratum: Golimumab in patients with acti

Erratum: Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

A148: A Multi-Center, Double-Blind, Rand

A148: A Multi-Center, Double-Blind, Randomized-Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results

✍ Brunner, Hermine; Ruperto, N.; Tzaribachev, N.; Horneff, G.; Wouters, C.; Panavi 📂 Article 📅 2014 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 53 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views